# US 2017/0321188 A1 · Methods of generating retinal progenitor cell preparations and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0321188 A1
- Document ID: US20170321188A1
- Status: Published application
- Kind: A1
- Application number: 15/587,254
- Filed: 2017-05-04
- Published: 2017-11-09
- Earliest claimed: 2016-05-04
- Assignees: The Research Foundation for The State University of New York
- Applicants: The Research Foundation for The State University of New York
- Inventors: Andrea S. VICZIAN; Michael E. ZUBER
- Web page: https://patentgrep.com/patent/US20170321188A1

## CPC

- A61K 35/30: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- C12N 5/0621: {Eye cells, e.g. cornea, iris pigmented cells (photoreceptors C12N5/062)}
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2506/02: from embryonic cells
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to methods of generating preparations of neural progenitor cells and retinal progenitor cells from populations of stem cells. These methods involve the administration of Tbx3 alone or in combination with Pax6. The preparations of neural and retinal progenitor cells prepared in accordance with the methods disclosed herein are suitable for use in methods of treating individuals having retinal disorders.

## Claims

### Claim 1

A method of producing an enriched preparation of neural progenitor cells from a population of pluripotent stem cells, said method comprising:
administering Tbx3 to the population of pluripotent stem cells and
culturing the population of pluripotent stem cells, to which Tbx3 has been administered, under conditions suitable to produce the enriched preparation of neural progenitor cells from the population of pluripotent stem cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method is carried out in vitro.

### Claim 3 (depends on 1)

The method of claim 1, wherein the pluripotent stem cells are embryonic stem (ES) cells, fetal tissue stem cells, or induced pluripotent stem cells (iPSc).

### Claim 4 (depends on 1)

The method of claim 1, wherein said Tbx3 is coupled to an intracellular delivery vehicle.

### Claim 5 (depends on 1)

The method of claim 1 further comprising:
contacting the enriched preparation of neural progenitor cells produced during or after said culturing with one or more reagents suitable to induce differentiation and production of retinal progenitor cells, neuronal progenitor cells, or glial progenitor cells from the preparation of neural progenitor cells.

### Claim 6 (depends on 5)

The method of claim 5, wherein the one or more reagents comprise Pax6 and said contacting induces differentiation and production of retinal progenitor cells.

### Claim 7 (depends on 1)

The method of claim 1 further comprising:
isolating neural progenitor cells from the population of pluripotent stem cells after said culturing.

### Claim 8 (depends on 1)

An enriched preparation of neural progenitor cells produced in accordance with the method of claim 1.

### Claim 9 (depends on 8)

A method of treating a retinal disorder, said method comprising:
selecting a subject having retinal disorder, and
administering, to said subject, the enriched preparation of neural progenitor cells of claim 8.

### Claim 10 (depends on 9)

The method of claim 9, wherein the retinal disorder is a degenerative eye disease selected from the group consisting of age-related macular degeneration, retinitis pigmentosa and cone-rod dystrophies.

### Claim 11

A method of producing an enriched preparation of retinal progenitor cells from a population of stem cells, said method comprising:
administering Tbx3 and Pax6 to the population of stem cells and
culturing the population of stem cells, to which Tbx3 and Pax6 have been administered, under conditions suitable to produce the enriched preparation of retinal progenitor cells from the population of stem cells.

### Claim 12 (depends on 11)

The method of claim 11, wherein the method is carried out in vitro.

### Claim 13 (depends on 11)

The method of claim 11, wherein the stem cells are pluripotent stem cells selected from the group consisting of embryonic stem (ES) cells, fetal tissue stem cells, or induced pluripotent stem cells (iPSc).

### Claim 14 (depends on 11)

The method of claim 11, wherein said Tbx3 and/or Pax6 are coupled to an intracellular delivery vehicle.

### Claim 15 (depends on 14)

The method of claim 14, wherein the intracellular delivery vehicle is selected from the group consisting of a cell penetrating peptide, a cationic amphiphilic-based delivery reagent, and a nanoparticle delivery vehicle.

### Claim 16 (depends on 11)

The method of claim 11, wherein said culturing is carried out under conditions suitable for retinal organoid formation.

### Claim 17 (depends on 16)

A preparation of retinal organoids formed in accordance with the method of claim 16.

### Claim 18 (depends on 11)

The method of claim 11 further comprising:
administering said enriched preparation of retinal progenitor cells formed during said culturing to the eye of a subject in need thereof.

### Claim 19 (depends on 11)

An enriched preparation of retinal progenitor cells produced in accordance with the method of claim 11.

### Claim 20 (depends on 19)

A method of treating a retinal disorder, said method comprising:
selecting a subject having a retinal disorder, and
administering, to said subject, the enriched preparation of retinal progenitor cells of claim 19.
